Ostial Corp Raises $7.5M in Series C Funding to Accelerate Growth

Ostial Corporation, a revolutionary medical technology company, just announced a major funding milestone: a $7M growth round led by Delos Capital, with AMED Ventures and other existing investors joining in. Ostial seeks to revolutionize aorto-ostial interventions, which could have a dramatic impact on patient care. This fresh wave of funding will undoubtedly help the company push the boundaries of what’s possible in the medical technology space.

Ostial is making strides in the commercialization of their FLASH System, backed by the support of Delos Capital and AMED Ventures. With their expanding sales and operations teams, they are accelerating the product into new and existing accounts, and pushing the boundaries of the current FLASH technology. Jon Bohane, General Manager and Chief Operating Officer of Ostial, is thrilled to be at the forefront of this innovative journey.

Incept LLC’s portfolio company, Ostial, has just received a major funding injection to launch its FLASH™ Aorto-Ostial Angioplasty System (FLASH System) into commercialization. This revolutionary dual balloon-based system will be supported by the doubling of its sales force and the execution of national programs. Not to mention, the company will also use the funds to expand its clinical research and scientific advisory and commence the development of the next-generation FLASH System.

Delos Capital’s Managing Partner, Henry Chen, has outlined a bold vision: to equip physicians with cutting-edge technology that can effectively treat coronary and peripheral cases with high risk factors. With Ostial poised on the horizon, there is great potential for creating partnerships with other innovative, synergistic technologies that can expand the cardiovascular platform beyond FLASH.

The FLASH System is revolutionizing the way aorto-ostial stenting is done! By utilizing a dual-balloon design, this groundbreaking catheter ensures complete and 360° stent apposition at the ostium. Not only does this improve patient outcomes, but also future interventions can be more easily accessed. The FLASH System is truly a game-changer in the world of angioplasty!

With the recent influx of capital, Ostial’s Vice President of Sales and Business Development, Michael Lankford, is thrilled to announce the expansion of the FLASH System into the ‘neck to waist’ market, giving physicians the opportunity to confidently treat aorto-ostial lesions. This is a major breakthrough for the growing global market demand and will ensure Ostial’s field team has the resources to reach more customers.

The FLASH System is revolutionizing the healthcare industry, with 350 hospitals in the United States now using the system and a whopping 19,000 commercial units sold to date. This cutting-edge technology is transforming the way medical professionals diagnose and treat patients, providing an innovative and reliable solution for a variety of health issues.

About Ostial Corporation

Ostial Corporation, based in Campbell, California, is revolutionizing aorto-ostial interventions with their groundbreaking FLASH Aorto-Ostial Angioplasty System. This innovative device gives physicians the confidence to treat ostial cases with total coverage of the lesion. The result? Streamlined vessel reaccess and improved patient outcomes. It’s no wonder Ostial is leading the charge in medical technology.

Leave a Comment